Entrada Therapeutics, Inc.

By person

16 insiders · 282 transactions

5.8×

Dipal Doshi holds 5.8 times base salary in stock. $3.69M of shares against $635.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Dipal Doshi last reported holding, valued at $7.13, the price Common Stock was last bought or sold at on the open market here, on 9 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Redmile Group, LLC entity

10% owner

$20.00M (1)

—

+$20.00M

1,954,420

5.02%

$13.94M

—

BAKER BROS. ADVISORS LP entity

10% owner

$2.59M (40)

—

+$2.59M

4,691,392

12.05%

$33.45M

+8.5%

MPM BioVentures 2014, L.P.

10% owner

$2.00M (1)

$4.52M (14)

−$2.52M

8,203,463

21.07%

$58.49M

+90.0%

MPM BIOVENTURES 2018, L.P.

10% owner

$2.00M (1)

$4.52M (14)

−$2.52M

8,203,463

21.07%

$58.49M

+90.0%

Foley Todd

Director

$2.00M (1)

—

+$2.00M

4,425,784

11.37%

$31.56M

—

WENTWORTH KORY JAMES

Chief Financial Officer

—

$1.91M (37) scheduled

−$1.91M

117,277

0.3012%

$836.19K

—

Sethuraman Natarajan

President, Research & Develop.

—

$1.90M (21) scheduled

−$1.90M

214,238

0.5502%

$1.53M

+64.1%

Dowden Nathan J

President & COO

—

$1.90M (31) scheduled

−$1.90M

196,060

0.5035%

$1.40M

+315.9%

Doshi Dipal

CEO

—

$1.39M (49)

−$1.39M

517,290

1.33%

$3.69M

+314.5%

KREHER NERISSA

Chief Medical Officer

—

$998.17K (24) scheduled

−$998.17K

40,037

0.1028%

$285.46K

—

5AM Ventures V, L.P. entity

10% owner

$5.00M (1)

$4.07M (13)

+$931.96K

3,877,094

9.96%

$27.64M

+1,071%

KIM PETER S

Director

$641.94K (11)

—

+$641.94K

104,330

0.2679%

$743.87K

+121.8%

PARMAR KUSH

Director

$5.00M (1)

$4.72M (14)

+$284.85K

2,691,337

6.91%

$19.19M

—

Crowley John F

Director

$48.58K (1)

—

+$48.58K

5,000

0.0128%

$35.65K

—

Zeiher Bernhardt G

Director

$29.32K (1)

—

+$29.32K

5,000

0.0128%

$35.65K

—

ROCHE HOLDING LTD entity

10% owner

—

2,813,525

7.23%

$20.06M

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Zeiher Bernhardt G

20 May 2026

Director

Buy indirect

5,000

$5.86

$29.32K

BAKER BROS. ADVISORS LP

20 Nov 2025

10% owner

Buy indirect

13,082

$9.07

$118.69K

BAKER BROS. ADVISORS LP

20 Nov 2025

10% owner

Buy indirect

1,186

$9.07

$10.76K

BAKER BROS. ADVISORS LP

20 Nov 2025

10% owner

Buy indirect

13,386

$9.07

$121.39K

BAKER BROS. ADVISORS LP

20 Nov 2025

10% owner

Buy indirect

1,213

$9.07

$11.00K

BAKER BROS. ADVISORS LP

12 Nov 2025

10% owner

Buy indirect

11,494

$7.95

$91.43K

BAKER BROS. ADVISORS LP

12 Nov 2025

10% owner

Buy indirect

1,040

$7.95

$8.27K

BAKER BROS. ADVISORS LP

12 Nov 2025

10% owner

Buy indirect

80,881

$7.73

$625.33K

BAKER BROS. ADVISORS LP

12 Nov 2025

10% owner

Buy indirect

7,321

$7.73

$56.60K

BAKER BROS. ADVISORS LP

11 Nov 2025

10% owner

Buy indirect

30,879

$7.54

$232.81K

BAKER BROS. ADVISORS LP

11 Nov 2025

10% owner

Buy indirect

2,795

$7.54

$21.07K

BAKER BROS. ADVISORS LP

11 Nov 2025

10% owner

Buy indirect

11,701

$7.39

$86.48K

BAKER BROS. ADVISORS LP

11 Nov 2025

10% owner

Buy indirect

1,059

$7.39

$7.83K

BAKER BROS. ADVISORS LP

10 Nov 2025

10% owner

Buy indirect

2,947

$7.22

$21.29K

BAKER BROS. ADVISORS LP

10 Nov 2025

10% owner

Buy indirect

267

$7.22

$1.93K

BAKER BROS. ADVISORS LP

10 Nov 2025

10% owner

Buy indirect

25,364

$7.21

$182.97K

BAKER BROS. ADVISORS LP

10 Nov 2025

10% owner

Buy indirect

2,296

$7.21

$16.56K

KIM PETER S

14 May 2024

Director

Buy

25,000

$14.59

$364.67K

KIM PETER S

9 May 2024

Director

Buy

2,200

$14.25

$31.34K

KIM PETER S

8 May 2024

Director

Buy

2,276

$14.04

$31.96K

KIM PETER S

8 Apr 2024

Director

Buy

2,600

$13.57

$35.29K

KIM PETER S

28 Mar 2024

Director

Buy

1,512

$13.75

$20.79K

KIM PETER S

26 Mar 2024

Director

Buy

2,750

$13.64

$37.51K

KIM PETER S

25 Mar 2024

Director

Buy

3,180

$13.36

$42.47K

KIM PETER S

22 Mar 2024

Director

Buy

3,118

$13.76

$42.90K

KIM PETER S

21 Mar 2024

Director

Buy

704

$13.24

$9.32K

KIM PETER S

20 Mar 2024

Director

Buy

1,128

$12.66

$14.28K

KIM PETER S

19 Mar 2024

Director

Buy

900

$12.66

$11.40K

BAKER BROS. ADVISORS LP

6 Jun 2022

10% owner

Buy indirect

26,450

$6.42

$169.85K

Showing 250 of 282 transactions. The figures above use every one of them.

Entrada Therapeutics, Inc.

By person

Individual transactions

What was left out